Simultaneous House, Senate Hearings On High Drug Prices Set The Stage For Pharma’s New Reality On Capitol Hill

The pharmaceutical industry was put on notice Tuesday when two powerful congressional committees placed high drug prices firmly at the top of their agendas. “Drug companies make money hand over fist by raising the prices of their drugs — often without justification and sometimes overnight — while patients are left holding the bill," said House Oversight and Reform Chairman Elijah Cummings (D-Md.) at the House hearing. Over in the Senate, Sen. Chuck Grassley (R-Iowa) was adamant about bringing drug company executives in front of lawmakers to answer questions on high costs.

from Kaiser Health News http://bit.ly/2sVznkT